Sleep Duration Linked to Health-Related QoL in Kidney Disease

THURSDAY, May 3, 2018 -- Sleep duration is associated with health-related quality of life among patients with chronic kidney disease (CKD), according to a study published online May 3 in the Clinical Journal of the American Society of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news

Related Links:

In conclusion, both RH and RfH constitute challenges in clinical practice and should be addressed as distinct clinical entities by trained professionals who are capable to identify comorbidities and provide specific, diversified, and individualized treatment. PMID: 30525180 [PubMed - as supplied by publisher]
Source: Jornal Brasileiro de Nefrologia - Category: Urology & Nephrology Tags: J Bras Nefrol Source Type: research
Authors: Hornstrup BG, Gjoerup PH, Wessels J, Lauridsen TG, Pedersen EB, Bech JN Abstract Background: Chronic kidney disease (CKD) is often associated with a blunted nocturnal BP decrease and OSA. However, it is not fully clear whether a relationship exists between reduction in renal function and obstructive sleep apnea (OSA) on the one hand and relative nocturnal BP decrease in CKD patients on the other. The aim of this study was to investigate the association between nocturnal BP decrease and renal function, the degree of OSA, vasoactive hormones, and renal sodium handling in CKD3-4 patients and healthy age-match...
Source: International Journal of Nephrology and Renovascular Disease - Category: Urology & Nephrology Tags: Int J Nephrol Renovasc Dis Source Type: research
The meta-analysis referenced in the"Obstructive Sleep Apnea" section should instead refer to a meta-analysis for chronic kidney disease. Additionally, there are two mis-numbered reference citations in the “chronic kidney disease” section (ref. 107 should ref. 104 [Wang C et al. 2014] and ref. 105.
Source: Current Hypertension Reports - Category: Primary Care Source Type: research
Catheter ablation (CA) is much more effective in reducing symptoms and rhythm control compared to anti-arrhythmic drugs and recommended as a first-line treatment for patients with symptomatic atrial fibrillation (AF) [1]. In spite of the ever-increasing evidences on benefits of CA, AF recurrence is common post CA and fewer AF patients are willing to accept ablation treatment in the clinical practice, which need to be taken consideration by the physicians before making the decision. Many clinical diseases or factors such as hypertension, type 2 diabetes mellitus, untreated obstructive sleep apnea, metabolic syndrome, chroni...
Source: International Journal of Cardiology - Category: Cardiology Authors: Tags: Editorial Source Type: research
Background: Obstructive sleep apnea syndrome (OSAS) is a syndrome characterized by respiratory patterns such as recurrent apnea or hypopnea during sleep and usually with desaturation. We aimed to present comorbid conditions of patients admitted to our clinic with OSAS diagnosis.Method: The records of 1969 patients who admitted to Sleep Disorders Laboratory of the Faculty of Medicine, Dicle University between 2008 and 2015 were retrospectively reviewed. The demographic characteristics, severity of OSAS, comorbidities of these patients were evaluated.Results: The apnea hypopnea index (AHI) of 529 patients was normal, 357 pat...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Sleep and control of breathing Source Type: research
Obstructive sleep apnea syndrome (OSAS) is well-known to be associated with high risk for cardiovascular diseases (CVD) associated risk factors such as diabetes mellitus, hypertension, chronic inflammation and chronic kidney disease. Recent studies showed that hyperosmolarity may cause chronic kidney disease and cardiovascular disease. Here we tested the association between serum osmolality and severity of OSAS and diabetes mellitus, hypertension. This was a cross-sectional study in which patients who had undergone a polysomnographic study were recruited. Included patients were grouped according to apnea-hypopnea index (AH...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Sleep and control of breathing Source Type: research
Conclusion: Like in HD patients, close follow-up of predialysis patients with CKD is critical considering the resolution of the encountered problems. We believe that the increase in QOL and sleep in patients with CKD may decrease the morbidity.
Source: Nigerian Journal of Clinical Practice - Category: Rural Health Authors: Source Type: research
Publication date: Available online 9 November 2018Source: Journal of the Formosan Medical AssociationAuthor(s): Chao-Ying Tu, Yu-Hsiang Chou, Yu-Hsuan Lin, Wei-Lieh HuangBackground/PurposeSleep disorder and depression are prevalent in patients on dialysis but less investigated in earlier-stage chronic kidney disease (CKD) patients. We aimed to evaluate the prevalence of depression, anxiety, health anxiety, and sleep disturbance and explore the association between CKD stage, psychological symptoms and sleep quality.MethodsWe recruited 326 patients with CKD (stage 1–5) not on dialysis from the nephrology clinic. All pa...
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research
Abstract BACKGROUND/PURPOSE: Sleep disorder and depression are prevalent in patients on dialysis but less investigated in earlier-stage chronic kidney disease (CKD) patients. We aimed to evaluate the prevalence of depression, anxiety, health anxiety, and sleep disturbance and explore the association between CKD stage, psychological symptoms and sleep quality. METHODS: We recruited 326 patients with CKD (stage 1-5) not on dialysis from the nephrology clinic. All participants completed the Beck Depression Inventory-II (BDI-II), Beck Anxiety Inventory (BAI), Health Anxiety Questionnaire (HAQ), and Pittsburgh Sle...
Source: J Formos Med Assoc - Category: General Medicine Authors: Tags: J Formos Med Assoc Source Type: research
As the epidemics of obesity and type 2 diabetes mellitus increase worldwide, the prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing proportionately. The subtype of NAFLD which can be characterized as non-alcoholic steatohepatitis (NASH) is a potentially progressive liver disease that can lead to cirrhosis, hepatocellular carcinoma, liver transplantation, and death; it is associated with extrahepatic manifestations such as chronic kidney disease cardiovascular disease and sleep apnea.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Public Health Source Type: research
More News: Chronic Kidney Disease | Pharmaceuticals | Sleep Disorders | Sleep Medicine | Study | Urology & Nephrology